Panitumumab-DOTA-<sup>111</sup>In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner–Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Panitumumab-DOTA-¹¹¹In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner–Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer

Published:2022-08-04 Issue:10 Volume:19 Page:3652-3663
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Facca Valerie J.¹^ORCID,Cai Zhongli¹^ORCID,Gopal Nakita E. K.²,Reilly Raymond M.¹³⁴^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 3M2, Canada

2. Faculty of Arts and Sciences, University of Toronto, Toronto, Ontario M5S 3G3, Canada

3. Department of Medical Imaging, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada

4. Joint Department of Medical Imaging and Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2C1, Canada

Funder

Canadian Institutes of Health Research

University of Toronto

Terry Fox Foundation

Amgen Canada

Natural Sciences and Engineering Research Council of Canada

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00457

Reference57 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Impact of breast cancer subtypes on prognosis of women with operable invasive breast cancer: a population-based study using SEER database

3. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up

4. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

5. NCCN Guidelines Breast Cancer, version 5.2021; National Comprehensive Cancer Network, 2021.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lead‐212/Bismuth‐212 In Vivo Generator Based on Ultrasmall Silver Telluride Nanoparticles;Journal of Labelled Compounds and Radiopharmaceuticals;2024-08-15

2. The application of radionuclide therapy for breast cancer;Frontiers in Nuclear Medicine;2024-01-10

3. Adjuvant Auger Electron-Emitting Radioimmunotherapy with [¹¹¹In]In-DOTA-Panitumumab in a Mouse Model of Local Recurrence and Metastatic Progression of Human Triple-Negative Breast Cancer;Molecular Pharmaceutics;2023-11-20

4. Development of Novel Trifunctional Chelating Agents That Enhance Tumor Retention of Radioimmunoconjugates;Journal of Medicinal Chemistry;2023-09-18